Dechert Advises Quest Diagnostics in Sale of Ownership Interest in Q2 Solutions
April 01, 2021
Dechert is advising Quest Diagnostics in the sale of its ownership interest in Q2 Solutions, a global leader in central laboratory services to support clinical trials of new pharmaceuticals, to IQVIA for $760 million in an all cash transaction. The deal was announced April 1, 2021. IQVIA previously owned a 60 percent majority share and Quest Diagnostics owned a 40 percent minority share.
The Dechert team includes corporate partners Michael Darby, Christopher Field, Douglas Getter and Ken Young, counsel James Stonehill, and associates Erin O’Gurek and Paul Bennett; tax partners Edward Lemanowicz and Daniel Hawthorne, and associates George Davis and Kalina Hannsz; antitrust partner James Fishkin, counsel Beverly Ang and Michael Okkonen, and associate Delphine Strohl; cybersecurity partner Karen Neuman, and associates Madeleine White and Michael Tierney; employee benefits partner Eric Rubin; labor counsel Ian Downes; regulatory partner Susan Hendrickson; real estate special counsel Francois Quintard-Morenas; and assisted by trainee solicitor Fahwad Khan.
About Dechert
Dechert is a leading global law firm with 25 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
